OTC : BAYRY

Bayer AG

$14.328 USD

$0.35 (2.49%)

Volume
75.6K
Average Volume
1.27M
Market Capitalization
$56.3B
P/E Ratio
-22.68
Dividend Yield
0.22%
Price Target
Year High
$15.23
Year Low
$7.19
Day High
—
Day Low
—
Payout Ratio
-$0.06
Current Ratio
$1.06
Company Overview

OTC

William N. Anderson

Drug Manufacturers - General

Healthcare

BAYRY

88078

DE

USD

https://www.bayer.com

49 214 30 1

072730302

N/A

Liquidity Metrics

1.35

1.06

0.70

0.17

-0.06

Sales & Valuation

$43.78B

1.08

1.69

24.24

0.51

Profitability

-$0.88

-$3.48B

-4.77%

-4.35%

-7.52%

-2.00%

P/E Metrics

-22.68

0.01

0.01

Analyst Price Target & Rating

Sell

2/5

3 Analysts

%

Financial Health Scores

0.93

4/9

$1.84B

$108.06B

$79.06B

$4.41B

Key Metrics (TTM)

$82.65B

1.83

23.57

1.06

-7.52%

8.42%

-4.36%

4.07%

242 days

Company Executives
Name Title
Jost Reinhard President of the Radiology Business for Pharmaceuticals Division
William N. Anderson Chairman of the Management Board & Chief Executive Officer
Daniella Foster SVP and Global Head of Public Affairs,Science & Sustainability for Bayer's Consumer Health Division
Alex Buschermohle Chief Information Officer, Head-Digital Transformation & IT-Crop Science Division
Rodrigo Santos Member of Management Board, Head of the Crop Science Division & President of Crop Science Division
Heike Prinz Chief Talent Officer, Labor Director & Member of Management Board
Stefan Oelrich President of the Pharmaceuticals Division & Member of the Board of Management
Judith Hartmann Chief Financial Officer & Member of Management Board
Bill Dodero General Counsel and Senior Vice President of Law Patents & Compliance
Julio Triana Member of Management Board & President of Consumer Health Division
Michael Preuss Head of Communications, Government Relations and Corporate Brand
Poll Results

No votes yet today — be the first to share your view!

About Bayer AG (OTC:BAYRY) Stock

Bayer Aktiengesellschaft, commonly known as Bayer AG, functions as a prominent global life sciences company through its various subsidiaries. Its extensive operations are strategically segmented into Pharmaceuticals, Consumer Health, and Crop Science. The Pharmaceuticals division concentrates on developing and marketing prescription medications, with key areas including cardiology and women's healthcare. It also offers specialized therapeutic solutions for oncology, hematology, and ophthalmology, alongside diagnostic imaging equipment, contrast agents, and advanced cell and gene therapies. Bayer's Consumer Health segment provides a wide array of non-prescription (over-the-counter) medicines, medical devices, medicated skincare items, and nutritional supplements. These self-care products ad ... dress diverse health needs such as dermatology, dietary support, pain relief, cardiovascular risk prevention, digestive issues, allergy management, and cold and cough symptoms. The Crop Science division supports the agricultural sector with chemical and biological crop protection products, genetically enhanced plant traits, seeds, digital farming tools, and solutions for pest and weed control. This segment also manages the breeding, propagation, production, and specialized treatment of seeds, complemented by dedicated customer service for farmers. Bayer is actively involved in numerous strategic collaborations to bolster its research and development pipeline. These partnerships include an agreement with MD Anderson Cancer Center for oncology drug development, a research and licensing deal with Dewpoint Therapeutics, Inc. focused on novel treatments for cardiovascular and gynecological diseases, and collaborations with Exscientia Ltd, Foundation Medicine Inc., Evotec AG, and Arvinas Inc. Additionally, the company maintains strategic research alliances with the University of Oxford for gynecological therapies and with Kyoto University to discover potential new drugs for pulmonary conditions. The company’s products reach a broad market through various distribution channels, including wholesale partners, independent and chain pharmacies, supermarkets, online and other retail outlets, hospitals, and direct sales to agricultural producers. Bayer Aktiengesellschaft was established in 1863 and is headquartered in Leverkusen, Germany.

Bayer Aktiengesellschaft (BAYRY) Q2 2026 Earnings Call Transcript

2026-08-04 13:30:01

Bayer Aktiengesellschaft (BAYRY) Q2 2026 Earnings Call Transcript

Bayer: De-Risking Is Real, But The Pharma Cliff Keeps Me On Hold

2026-08-04 13:21:32

Bayer A.G. receives a Hold rating, reflecting cautious optimism after a solid Q2 but ongoing de-risking needs. Crop Science delivers growth and margin expansion, while recent Roundup litigation outcomes significantly reduce existential risk. Pharma faces revenue and margin headwinds as NUBEQA and KERENDIA ramp-up is not yet offsetting EYLEA/XARELTO patent cliffs.

BAYRY Beats on Q2 Earnings, Crop Science Business Boosts Growth

2026-08-04 13:01:22

Bayer tops Q2 estimates as Crop Science and fast-growing drugs offset pressure from patent-expired brands, while reaffirming its 2026 outlook.

Bayer Aktiengesellschaft Q2 Earnings Call Highlights

2026-08-04 04:03:04

Bayer Aktiengesellschaft ETR: BAYN said first-half sales rose 3% on a currency- and portfolio-adjusted basis to €24.3 billion, as growth in Crop Science and Consumer Health offset pressure in parts of its pharmaceutical business. The company reiterated its full-year 2026 outlook and lowered its net financial debt target after a €3 billion equity investment from Apollo.

Bayer Swings to Net Profit on Smaller Litigation Charges

2026-08-04 02:11:00

The company said its 2026 sales and earnings forecasts were unchanged when adjusted for currency changes, and that year-end net debt would be lower than originally projected.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Short Interest Update

2026-07-30 01:41:23

Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report) was the recipient of a large growth in short interest during the month of July. As of July 15th, there was short interest totaling 268,144 shares, a growth of 88.7% from the June 30th total of 142,122 shares. Based on an average trading volume of 1,758,154 shares, the

New Economist Enterprise Research Highlights Why Integrating Self-Care Into Health Systems Matters

2026-07-23 13:03:00

LEVERKUSEN, Germany--(BUSINESS WIRE)--Self-care, when effectively integrated into health systems, can improve health outcomes, expand access to healthcare services and reduce pressure on overstretched health systems, according to new research by Economist Enterprise. The research, supported by Bayer and published in a report titled “Making self-care work: integrating self-care into health systems”, cites existing evidence estimating that self-care practices can deliver approximately US$ 179 bil.

Bayer and Henry Ford Health Announce Strategic Research Partnership to Expand Patient Access to Clinical Trials

2026-07-17 08:30:00

DETROIT--(BUSINESS WIRE)--Bayer, a global life sciences company, and Henry Ford Health today announced a strategic partnership to expand clinical trial opportunities for patients. The work brings together Bayer's global drug development expertise with Henry Ford Health's comprehensive clinical research program and its deep connection to the communities it serves. “Clinical trials are often the first opportunity patients have to access cutting-edge treatments,” said Dr. David Lanfear, Chief Scie.

Frequently Asked Questions

What is the current Bayer AG (BAYRY) stock price?

Bayer AG(OTC:BAYRY) stock price is $14.328 in the last trading session. During the trading session, BAYRY stock reached the peak price of $15.23 while $7.19 was the lowest point it dropped to. The percentage change in BAYRY stock occurred in the recent session was 2.49% while the dollar amount for the price change in BAYRY stock was $0.35.

BAYRY's industry and sector of operation?

The OTC listed BAYRY is part of Drug Manufacturers - General industry that operates in the broader Healthcare sector.

Who are the executives of BAYRY?

Jost Reinhard | President of the Radiology Business for Pharmaceuticals Division
William N. Anderson | Chairman of the Management Board & Chief Executive Officer
Daniella Foster | SVP and Global Head of Public Affairs,Science & Sustainability for Bayer's Consumer Health Division
Alex Buschermohle | Chief Information Officer, Head-Digital Transformation & IT-Crop Science Division
Rodrigo Santos | Member of Management Board, Head of the Crop Science Division & President of Crop Science Division

How many employees does BAYRY have?

Number of BAYRY employees currently stands at 88078. BAYRY operates from Kaiser-Wilhelm-Allee 1, Leverkusen, NW 51368, DE.

Link for BAYRY official website?

Official Website of BAYRY is: https://www.bayer.com

How do I contact BAYRY?

BAYRY could be contacted at phone #49 214 30 1 and can also be accessed through its website. BAYRY operates from Kaiser-Wilhelm-Allee 1, Leverkusen, NW 51368, DE.

How many shares of BAYRY are traded daily?

The average number of BAYRY shares traded daily for last 3 months was 1.27M.

What is the market cap of BAYRY currently?

The market value of BAYRY currently stands at $56.3B with its latest stock price at $14.328